HCV-IN-35
Product Specifications
UNSPSC Description
HCV-IN-35 (Compound (R)-3h) is a potent inhibitor of HCV. HCV-IN-35 has the potential for the research infection diseases[1].
Target Antigen
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-in-35.html
Solubility
10 mM in DMSO
Smiles
N#CC(C=CC(N(C)CCN(C)C)=C1)=C1CN(CC2)CCN2[C@H](C3=CC=CC=C3)C4=CC=C(C=C4)Cl
Molecular Weight
502.09
References & Citations
[1]Wang Y, et al. Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65(3):2107-2121.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-144108/HCV-IN-35-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-144108/
Clinical Information
No Development Reported
CAS Number
2757963-82-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
